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Abstract. 
 
Ubiquitin-dependent proteolysis of Cut2/
Pds1 and Cyclin B is required for sister chromatid sepa-
ration and exit from mitosis, respectively. Anaphase-
promoting complex/cyclosome (APC) speciﬁcally ubiq-
uitinates Cut2/Pds1 at metaphase–anaphase transition, 
and ubiquitinates Cyclin B in late mitosis and G1 phase. 
However, the exact regulatory mechanism of substrate-
speciﬁc activation of mammalian APC with the right 
timing remains to be elucidated. We found that not only 
the binding of the activators Cdc20 and Cdh1 and the 
inhibitor Mad2 to APC, but also the phosphorylation of 
Cdc20 and Cdh1 by Cdc2-Cyclin B and that of APC by 
Polo-like kinase and cAMP-dependent protein kinase, 
regulate APC activity. The cooperation of the phos-
phorylation/dephosphorylation and the regulatory fac-
tors in regulation of APC activity may thus control the 
precise progression of mitosis.
Key words: anaphase-promoting complex • Cdc20 • 
Cdh1 • Mad2 • phosphorylation
 
U
 
BIQUITIN
 
-mediated protein destruction plays a crit-
ical role in regulation of cell cycle progression,
and is a particularly effective method for promot-
ing unidirectional progression in the cell cycle because of
its irreversibility (Murray et al., 1989; King et al., 1994,
1996; Hershko, 1997; Peters, 1998; Koepp et al., 1999; Mor-
gan, 1999). Proteolysis of the Cut2/Pds1, which triggers sis-
ter chromatid separation, is required for the metaphase–
anaphase transition and degradation of mitotic cyclin, and
Ase1 is essential for exit from mitosis (Glotzer and Mur-
ray, 1991; Holloway et al., 1993; Irniger et al., 1995; Co-
hen-Fix et al., 1996; Funabiki et al., 1996).
Anaphase-promoting complex/cyclosome (APC)
 
1
 
 func-
tions as a cell cycle–regulated ubiquitin ligase that mediates
destruction of these cell cycle regulatory factors by the pro-
teasomes during mitosis. It is activated at metaphase–
anaphase transition and remains active until late G1 phase
(Amon et al., 1994; King et al., 1995; Lahav-Baratz et al.,
1995; Sudakin et al., 1995; Tugendreich et al., 1995; Peters
et al., 1996; Zachariae et al., 1998a; Yu et al., 1998). The
APC is a 20S/36S particle, most of whose core subunits
were recently identified (Yu et al., 1998; Zachariae et al.,
1998a), but the precise regulatory mechanism of APC acti-
vation has remained unresolved.
The APC activity has been thought to be regulated by
cell cycle–specific phosphorylation and dephosphorylation
(King et al., 1995; Lahav-Baratz et al., 1995; Sudakin et al.,
1995; Ishii et al., 1996; Peters et al., 1996; Yamashita et al.,
1996; Patra and Dunphy, 1998; Yu et al., 1998). It was re-
ported that APC is controlled by Cdc2-Cyclin B (MPF) by
reversible phosphorylation (Hershko et al., 1994; Lahav-
Baratz et al., 1995; Sudakin et al., 1995; Shteinberg and
Hershko, 1999; Shteinberg et al., 1999). Recently, the spe-
cific kinases that regulate APC activity were identified.
Polo-like kinase (Plk) (Glover et al., 1998), a homologue of
 
Drosophila
 
 polo and budding yeast Cdc5, phosphorylates
at least three APC subunits, APC1, APC3, and APC6, and
activates APC (Charles et al., 1998; Descombes and Nigg,
1998; Kotani et al., 1998; Shirayama et al., 1998), whereas
cAMP-dependent protein kinase (PKA) phosphorylates
APC1 and APC3 (Kotani et al., 1998) and suppresses APC
activity (Ishii et al., 1996; Yamashita et al., 1996; Yamada
et al., 1997; Kotani et al., 1998). Furthermore, PP1 has
been found to be required for the activation of APC in
metaphase–anaphase transition (Ishii et al., 1996). There-
fore, it became clear that phosphorylation and dephos-
phorylation of APC plays an important role in regulation
of APC activity during mitosis.
On the other hand, recent genetic and biochemical anal-
yses in yeast, 
 
Drosophila
 
, and 
 
Xenopus
 
 have indicated that
 
APC is activated by the WD-repeat proteins, Cdc20/
p55CDC/Fizzy (Cdc20) and Cdh1/Hct1/Fizzy-related (Cdh1),
in a substrate-specific manner (Visintin et al., 1997; Schwab et
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al., 1997; Sigrist and Lehner, 1997; Kallio et al., 1998; Fang
et al., 1998a,b; Kramer et al., 1998; Lorca et al., 1998; Za-
chariae et al., 1998b), whereas APC is inactivated by a spin-
dle assembly checkpoint through Mad2 (He et al., 1997; Li
et al., 1997; Fang et al., 1998b; Gorbsky et al., 1998; Hwang
et al., 1998; Kallio et al., 1998; Kim et al., 1998). Very re-
cently, it was reported that whereas Mad1, Mad2, Mad3/
Bub1, and Bub3 suppress Cdc20-dependent APC activa-
tion, Bub2 localized in the spindle pole body regulates
Cdh1-dependent APC activation (Alexandru et al., 1999;
Fesquet et al., 1999; Fraschini et al., 1999). Furthermore, it
was found that Cdc14, of which activity is regulated by
Bub2/Byr4 and RENT complex (Alexandru et al., 1999;
Shou et al., 1999; Visintin et al., 1999), dephosphorylates
Cdh1/Hct1 and inactivates APC (Visintin et al., 1998).
Therefore, APC activity is regulated by at least four dis-
tinct mechanisms: activation and inactivation by phos-
phorylation and dephosphorylation of APC itself; activa-
tion by the binding of substrate-specific activators Cdc20
and Cdh1 to APC; suppression of APC activity by the
spindle assembly checkpoint through Mad family and Bub
family; and regulation of APC activity by Bub2/RENT
complex system. However, the precise regulatory mecha-
nism of substrate-specific activation of mammalian APC
with the right timing through these complicated mecha-
nisms remains to be elucidated.
We found that not only the binding of the activators
Cdc20 and Cdh1 and the inhibitor Mad2 to APC, but also
the phosphorylation of Cdc20 and Cdh1 by MPF and that
of APC by Plk and PKA, regulate the timing of APC acti-
vation. We discuss here the regulatory mechanism of APC
activation.
 
Materials and Methods
 
cDNA Cloning and Plasmid Constructs
 
Human Cdc20 and Mad2 cDNA were prepared by reverse transcriptase–
PCR. Two human expressed sequence tags homologous to Cdh1/Hct1
were used as probes for the screening of full-length human Cdh1 cDNA in
a 
 
l
 
gt10 human erythroleukemia K562 cDNA library. The T7- and His
 
6
 
-
tagged Cdc20, Cdh1, and Mad2 in pET-23d were expressed in NovaBlue
(DE3) in the presence of 0.5 mM isopropyl-
 
b
 
-
 
D
 
-thiogalactopyranoside at
25
 
8
 
C for 20 h. The cell lysates were solubilized (10 mM Tris, pH 8.0, 0.1 M
NaH
 
2
 
PO
 
4
 
, and 6 M guanidine isothiocyanate), bound to His-Bind resins,
washed (10 mM Tris, pH 8.0, 0.1 M NaH
 
2
 
PO
 
4
 
, and 8 M urea) five times,
eluted (10 mM Tris, pH 4.5, 0.1 M NaH
 
2
 
PO
 
4
 
, and 8 M urea), and dia-
lyzed. Rabbit antisera against tagged Cdc20 and Cdh1 were prepared and
each specific antibody was purified by antigen affinity chromatography.
 
In Vitro Kinase Assay
 
The purified Cdc20, Cdh1, or Mad2 (1 
 
m
 
g) was incubated with 10 
 
m
 
Ci of
 
g
 
-[
 
32
 
P]ATP (3,000 Ci/mmol) and human Cdc2-GST-Cyclin B prepared by
baculovirus (0.1 
 
m
 
g) (Kotani et al., 1998) or Plk (0.1 
 
m
 
g) (Kotani et al.,
1998) in 50 
 
m
 
l of a kinase buffer (MPF: 10 mM Tris, pH 7.4, 10 mM MgCl
 
2
 
,
0.1 mM EGTA, and 0.05% 
 
b
 
-mercaptoethanol; Plk: 20 mM Tris, pH 7.4,
10 mM MgCl
 
2
 
, 25 mM NaCl, 0.2 mg/ml BSA, and 0.05% 
 
b
 
-mercaptoetha-
nol), at 37
 
8
 
C for 30 min. The labeled proteins were immunoprecipitated
with anti-T7 mAb (Novagen), washed, and resolved in 7% SDS-PAGE.
The immunoprecipitates of anti–Cyclin B1-specific antibody in nocoda-
zole-treated K562 cell extracts were incubated with 10 
 
m
 
Ci of 
 
g
 
-[
 
32
 
P]ATP
in 20 
 
m
 
l of MPF kinase buffer at 30
 
8
 
C for 1 h. 1 
 
m
 
l of 20% SDS was added,
 
mixed, and the sample was centrifuged. The sample was diluted with 500 
 
m
 
l
of the kinase buffer and the labeled Cdc20 and Cdh1 were immunoprecip-
itated with anti–Cdc20- or anti–Cdh1-specific antibody, respectively. The
samples were resolved in 7% SDS-PAGE.
 
Preparation of APC
 
Mouse NIH3T3 cells were maintained in DME supplemented with 10%
FCS. Cells were synchronized at the G1/S boundary by double blocking
with 1 
 
m
 
g/ml aphidicolin and harvested 2 h after drug release. APC in the
S phase was prepared by Resource Q chromatography and immunopre-
cipitation with anti-Cdc27 antibody (a gift of Drs. P. Hieter and A. Page,
University of British Columbia, Vancouver, Canada) as described (Kotani
et al., 1998). Immunoprecipitates were washed three times with a buffer
containing 500 mM KCl to remove MPF and Plk, and then washed with
the buffer for kinase or ubiquitination reaction.
 
Ubiquitination Assay
 
Cdc20 and Cdh1 (1 
 
m
 
g) were phosphorylated by incubating with 0.1 
 
m
 
g of
Cdc2-GST-Cyclin B and 0.1 mM ATP in 10 
 
m
 
l of MPF kinase buffer at
37
 
8
 
C for 30 min. The phosphorylated Cdc20 and Cdh1 were bound to His-
Bind resin, washed with the kinase buffer containing 0.5 M KCl three
times to remove MPF, and washed with the ubiquitination buffer. In some
cases, the purified APC was phosphorylated by PLK phosphorylated by
MPF (pPlk) and/or PKA in 50 
 
m
 
l of Plk kinase buffer containing 1 mM
ATP, 0.1 
 
m
 
g of human Cdc2-GST-Cyclin B prepared by baculovirus (Ko-
tani et al., 1998) and 0.1 
 
m
 
g of Plk, or in PKA buffer (10 mM Tris, pH 7.4,
10 mM MgCl
 
2
 
, and 0.1 mM EGTA) with 0.5 
 
m
 
g of bovine PKA catalytic
subunit, and washed twice with 5 mM Tris, pH 7.6, and 0.5 mM MgCl
 
2
 
.
The phosphorylated or untreated APC was incubated with 2 
 
m
 
g of GST-
Cut2 (a gift of Dr. M. Yanagida, Kyoto University, Kyoto, Japan) (Funa-
biki et al., 1997) or 2 
 
m
 
g of human Cdc2-GST-Cyclin B (a gift of Dr. N.
Watanabe, RIKEN, Japan) (Kotani et al., 1998) in the presence of various
amounts (0–1 
 
m
 
g) of phosphorylated or unphosphorylated forms of Cdc20
and Cdh1 in 30 
 
m
 
l of 5 mM Tris, pH 7.6, 0.5 mM MgCl
 
2
 
, 2 mM ATP, 2 mM
DTT, 2 mM creatine phosphate, 1 
 
m
 
g/ml creatine phosphokinase, 0.2 mg/
ml bovine ubiquitin (Sigma Chemical Co.), 40 
 
m
 
g/ml mouse recombinant
E1 and 50 
 
m
 
g/ml human recombinant hE2-C (Kotani et al., 1998), and
then incubated at 25
 
8
 
C for 30 min or the indicated time. The samples were
applied to 7% SDS-PAGE, and the ubiquitinated GST-Cyclin B or GST-
Cut2 was detected by immunoblotting with anti–Cyclin B1 antibody and
anti–GST antibody, respectively, and visualized by the enhanced chemilu-
minescence reaction.
 
Binding Assay
 
The purified APC in the S phase, which was immunoprecipitated with
anti–Cdc27 antibody, was incubated with or without pPlk or PKA as de-
scribed. The pretreated APC was incubated with T7-tagged human Cdc20,
pCdc20, Cdh1, or Cdh1-phosphorylated MPF (pCdh1) in the ubiquitina-
tion buffer at 25
 
8
 
C for 30 min, washed with the buffer five times, and the
proteins bound to the APC were resolved by 7% SDS-PAGE. The bound
proteins were detected by immunoblotting with anti-T7 antibody.
The purified S phase APC was incubated with Cdc2-GST-Cyclin B and
 
g
 
-[
 
32
 
P]ATP in the presence of Cdc20 or Cdh1 in MPF kinase buffer at
37
 
8
 
C for 30 min. The 
 
32
 
P-labeled proteins were immunoprecipitated by
anti–Cdc27 antibody and were resolved in 7% SDS-PAGE.
 
Results
 
MPF Phosphorylates Cdc20 and Cdh1
 
The T7-tagged human Cdc20, Cdh1, and Mad2 were pre-
pared in 
 
Escherichia coli
 
, and their possible kinases, hu-
man Cdc2-GST-Cyclin B (MPF) prepared by baculovirus
and His-tagged Plk produced in 
 
E
 
.
 
 coli
 
, were homoge-
neously purified as shown in Fig. 1 A. The in vitro phos-
phorylation was performed by incubating these recombi-
nant Cdc20, Cdh1, and Mad2 with recombinant MPF or
Plk in the presence of 
 
g
 
-[
 
32
 
P]ATP. Both Cdc20 and Cdh1
could be phosphorylated by MPF (Fig. 1 B, lanes 1 and 3)
but not by Plk (Fig. 1 B, lanes 2 and 4) in vitro. Mad2 was
not phosphorylated by these kinases (data not shown).
 
Mpf with but Not without Suc1/Cks1 Phosphorylates APC
 
Next, we performed in vitro phosphorylation of APC by 
Kotani et al. 
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MPF in the presence or absence of recombinant purified
human Suc1/Cks1 (CksHs-1 or CksHs-2). There exist two
human Suc1/Cks1 homologues, CksHs-1 and CksHs-2. As
shown in Fig. 1 C, none of the APC core subunits could be
phosphorylated by MPF alone (Fig. 1 C, lane 1). In the
presence of CksHs-1 (Fig. 1 C, lane 3) or CksHs-2 (Fig. 1
C, lane 4), however, MPF could clearly phosphorylate
APC1/Tsg24 and APC3/Cdc27 but not APC6/Cdc16,
which is consistent with the results of Patra and Dunphy
(1998). The MPF-activated Plk could phosphorylate APC1/
Tsg24, APC3/Cdc27, APC6/Cdc16, and an unidentified pro-
tein of 85 kD (Fig. 1 C, lane 2) as we previously showed
(Kotani et al., 1998). In the presence of all three compo-
nents (MPF, CksHs-1 or CksHs-2, and Plk), these APC
core subunits were most efficiently phosphorylated (Fig. 1
C, lanes 5 and 6). These results indicate that none of the APC
core subunits can be phosphorylated by MPF alone, but in
the presence of Suc1/Cks1, two APC core subunits, APC1/
Tsg24 and APC3/Cdc27, can be phosphorylated by MPF.
 
pCdc20 but Not Cdc20 Activates Ubiquitination of 
Cut2 and Cyclin B
 
In vitro reconstituted ubiquitination assay was performed to
assess the substrate- and time-specific activation or inactiva-
tion of mammalian APC, and the effects of phosphorylation
of the regulatory factors as well as APC on the ubiquitina-
tion activity were determined. Fig. 2, A and B, show that
Figure 1. In vitro phosphorylation of Cdc20, Cdh1, and APC by MPF. (A) The
Coomassie staining of the purified recombinant kinases, MPF (lane 1) and Plk
(lane 2), and the recombinant substrates, Cdc20 (lane 3), Cdh1 (lane 4), and Mad2
(lane 5). (B) Human T7–tagged Cdc20 (lanes 1 and 2) or Cdh1 (lanes 3 and 4) was
incubated with MPF (lanes 1 and 3) or Plk (lanes 2 and 4) and g-[32P]ATP in a ki-
nase buffer. The 32P-labeled Cdc20 and Cdh1 were immunoprecipitated by anti-
T7 antibody and resolved in 7% SDS-PAGE. Numbers at left indicate the posi-
tions of molecular mass markers in kilodaltons. (C) In vitro phosphorylation of
APC by MPF with or without Suc1/Cks1 (CksHs-1 or CksHs-2). In vitro kinase
assays were performed in the presence of CksHs-1 (lanes 3 and 5), CksHs-2 (lanes
4 and 6), Plk (lanes 2, 5, and 6), MPF (lanes 1–6), and APC (lanes 1–6). Arrows in-
dicate the labeled APC1/Tsg24, APC3/Cdc27, APC6/Cdc16, and an unidentified
protein of 85 kD. 
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the purified APC in the S phase had no activity to ubiqui-
tinate GST-Cut2 (Fig. 2 A, lane 1) or GST-Cyclin B (Fig. 2
B, lane 1), even in the presence of Cdc20 (Fig. 2, A and B,
lanes 2 and 3).
Since we found that Cdc20 could be phosphorylated by
MPF, we next examined the effect of Cdc20 phosphory-
lated by MPF (pCdc20) on APC activity. The Cdc20 was
phosphorylated by MPF, bound to His-Bind resin, and
washed with 0.5 M KCl to remove MPF. It was confirmed
by the immunoblot and MPF assay that the pCdc20 pre-
pared in this way was free of MPF (data not shown). Inter-
estingly, when the APC was incubated with pCdc20, both
GST-Cut2 and GST-Cyclin B were ubiquitinated in a
dose-dependent manner (Fig. 2, A and B, lanes 4–6). Fur-
thermore, Mad2 inhibited these ubiquitination activities in
a dose-dependent manner (Figs. 2, A and B, lanes 7 and
8). These results indicate that pCdc20 but not Cdc20 acti-
vates ubiquitination of both Cut2/Pds1 and Cyclin B, and
the pCdc20-dependent APC activation can be suppressed
by Mad2.
 
Cdh1 but Not pCdh1 Activates Ubiquitination of 
Cyclin B but Not Cut2
 
No GST-Cut2 was ubiquitinated even in the presence of a
large excess of Cdh1 (Fig. 3 A, lanes 2 and 3) or Cdh1
phosphorylated by MPF (pCdh1) (Fig. 3 A, lanes 4 and 5).
The pCdh1 was prepared by the same procedure as
Figure 2. The pCdc20 but not Cdc20 activates ubiquiti-
nation of Cut2 and Cyclin B. In vitro ubiquitination as-
says were performed with purified mouse APC in S
phase in the presence or absence of various amounts of
Cdc20, pCdc20, and Mad2 as indicated. Cdc20 was
phosphorylated by MPF and called pCdc20. The
pCdc20 was purified by His-bind chromatography and
washing with 0.5 M KCl to remove MPF. Activity to
ubiquitinate GST-Cut2 (A) or GST-Cyclin B (B) was
measured in the presence of recombinant E1 and hE2-C
in the ubiquitination buffer. Reaction mixes were ap-
plied to 7% SDS-PAGE, and the polyubiquitinated
GST-Cut2 and GST-Cyclin B were detected by immu-
noblotting with anti–Cyclin B antibody and anti–GST
antibody, respectively. Polyubiquitinated GST-Cut2
and Cyclin B bands are shown as Ub-Cut2 and Ub-
Cyclin B, respectively. Arrows indicate the positions of
nonubiquitinated GST-Cut2 and GST-Cyclin B. Num-
bers at left indicate the positions of molecular mass
marker in kilodaltons.
Figure 3. The Cdh1 but not pCdh1 activates ubiquiti-
nation of Cyclin B but not Cut2. In vitro ubiquitina-
tion assays were performed with purified mouse APC
in S phase in the presence or absence of various
amounts of Cdh1, pCdh1, and Mad2 as indicated.
Cdh1 was phosphorylated by MPF, and purified by
His-bind chromatography and washing with 0.5 M
KCl to remove MPF. Activity to ubiquitinate GST-
Cut2 (A) or GST-Cyclin B (B) was measured in the
presence of recombinant E1 and hE2-C in the ubiqui-
tination buffer. Reaction mixes were applied to 7%
SDS-PAGE, and immunoblotted with anti–Cyclin B
antibody and anti–GST antibody, respectively. Poly-
ubiquitinated Cyclin B bands are shown as Ub-Cyclin
B. Arrows indicate the positions of nonubiquitinated
GST-Cut2 and GST-Cyclin B. Numbers at left indi-
cate the positions of molecular mass marker in kilo-
daltons. 
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pCdc20, and it contained no MPF activity. The ubiquitina-
tion of GST-Cyclin B was activated by Cdh1 in a dose-
dependent manner (Fig. 3 B, lanes 1–4), and the activation
was not blocked by the addition of a large excess of Mad2
(Fig. 3 B, lane 5). In contrast, even sufficiently large
amounts of pCdh1 could not activate the ubiquitination of
GST-Cyclin B (Fig. 3 B, lanes 6 and 7). These results indi-
cate that APC in the presence of Cdh1 but not pCdh1, ef-
fectively and specifically ubiquitinates Cyclin B (but not
Cut2/Pds1) at least in vitro, and that Mad2 suppresses only
pCdc20-dependent APC activation.
 
Positive and Negative Effects of APC Phosphorylation 
by pPlk and PKA on Ubiquitination Activity in the 
Presence of pCdc20 or Cdh1
 
Next, we examined the effect of phosphorylation of APC
itself on APC activity in the presence of the activated form
of the regulatory factors, pCdc20 and Cdh1. As previously
reported, the pPlk-activated APC (pAPC) ubiquitinated
GST-Cyclin B (Fig. 4, lower panel, lane 1), but its activa-
tion was suppressed by phosphorylation with PKA (Fig. 4,
lower panel, lane 3). However, pAPC could not ubiquiti-
nate GST-Cut2 (Fig. 4, upper panel, lane 1). Furthermore,
if the APC or pAPC was once phosphorylated by PKA,
the GST-Cyclin B could not be ubiquitinated even in the
presence of the active regulatory factors, pCdc20 or Cdh1
(Fig. 4, lower panel, lanes 4–7). These results indicate that
the ubiquitination of Cyclin B is suppressed by PKA as
well as by Mad2, and that pPlk specifically stimulates the
ubiquitination of Cyclin B but not Cut2/Pds1.
 
pCdc20 or Cdh1 Acts Synergistically with pPlk on 
Cyclin B Ubiquitination
 
Time course experiments of Cyclin B ubiquitination with
pAPC demonstrated that the kinetics of the ubiquitination
reaction became much faster in the presence of the active
regulatory factors, pCdc20 (Fig. 5 A) or Cdh1 (Fig. 5 B),
i.e., a shorter incubation time (10 min) was enough to
reach the saturation level of GST-Cyclin B ubiquitination
(Fig. 5, A and B, lane 8), indicating that pCdc20 or Cdh1
acts synergistically with pPlk on Cyclin B ubiquitination. It
was also found that Mad2 does not inhibit pAPC activity
(Fig. 5 A, lane 10); thus, Mad2 inhibits only pCdc20-
dependent APC activation, whereas PKA suppresses both
pCdc20- and pPlk-dependent APC activation.
 
Binding of Cdc20, pCdc20, and Cdh1 to APC and pAPC
 
The binding assay of the regulatory factors to APC dem-
onstrated that both Cdc20 and pCdc20 constitutively
bound to APC (Fig. 6 A, lanes 1 and 2) and to pAPC (Fig.
6 A, lanes 7 and 8) but not to APC phosphorylated by
PKA (pAPC(PKA)) (Fig. 6 A, lanes 13 and 14). These re-
sults indicate that pCdc20-induced APC activation is
dependent on the phosphorylation of Cdc20 with MPF
rather than on the binding preference of pCdc20 to APC.
Furthermore, the binding of Cdc20 and pCdc20 to APC or
to pAPC was not affected by the addition of Mad2 (Fig. 6
A, lanes 3, 4, 9, and 10), suggesting that Mad2 inhibition of
pCdc20-induced APC activation is not due to the binding
inhibition of pCdc20 to APC, but due to the direct func-
tional inhibition of pCdc20 by Mad2. In contrast, Cdh1
could bind to either APC (Fig. 6 A, lane 5) or pAPC (Fig.
6 A, lane 11) but not to pAPC(PKA) (Fig. 6 A, lane 15),
whereas pCdh1 did not bind to any forms of APC (Fig. 6
A, lanes 6, 12, and 16). This indicates that Cdh1-induced
APC activation totally depends on the binding of Cdh1 to
APC or pAPC. These results suggest that Cdh1 (but not
pCdh1) specifically binds to and activates APC, and that
the PKA-induced inhibition of APC activity is due to the
inhibition of the binding of these active regulatory factors
to APC.
To confirm these binding data, the purified S phase APC
was incubated with Cdc2-GST-Cyclin B and 
 
g
 
-[
 
32
 
P]ATP in
the presence of Cdc20 or Cdh1, and the 
 
32
 
P-labeled pro-
teins were immunoprecipitated by anti–Cdc27 antibody.
The results showed that MPF directly phosphorylated
Figure 4. Suppression of pCdc20-, Cdh1-, or pPlk-induced
APC activation by PKA phosphorylation. Purified APC
was phosphorylated by pPlk and/or PKA, and Cdc20 was
phosphorylated by MPF. APC phosphorylated by pPlk
and/or PKA (indicated by 1) was incubated with GST-
Cut2 (top panel) or human GST-Cyclin B (bottom panel)
in the presence (1) or absence (no mark) of pCdc20 and
Cdh1 in the ubiquitination buffer at 258C for 30 min. Sam-
ples were applied to 7% SDS-PAGE and ubiquitinated
GST-Cyclin B or GST-Cut2 was detected by immunoblot-
ting with anti–Cyclin B1 antibody and anti–GST antibody,
respectively, and visualized by the enhanced chemilumi-
nescence reaction. 
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Cdc20 but none of the components of the purified APC
(Fig. 6 B, lane 1), and that pCdc20 actually bound to APC
(Fig. 6 B, lane 1) but pCdh1 could not bind to APC (Fig. 6
B, lane 2). These results also confirmed that there is no
need to consider the effect of phosphorylation of APC by
MPF on ubiquitination activity.
 
MPF Phosphorylates Cdc20 and Cdh1 during Mitosis
In Vivo
 
To demonstrate that MPF phosphorylates Cdc20 and
Cdh1 during mitosis in vivo, the immunoprecipitates of
anti–Cyclin B-specific antibody from mitotic K562 cell ex-
tracts were incubated with 
 
g
 
-[
 
32
 
P]ATP in MPF kinase
buffer. The sample was washed with 1% SDS, diluted
25-fold with the kinase buffer, and the labeled Cdc20 and
Cdh1 were immunoprecipitated with anti–Cdc20- or anti–
Cdh1-specific antibody, respectively. The 
 
32
 
P-labeled Cdc20
and Cdh1 can be clearly seen (Fig. 7, lanes 2 and 3). Fig. 7,
lane 1, shows the total 
 
32
 
P-labeled proteins without immu-
noprecipitation by anti–Cdc20 or anti–Cdh1 antibody, and
the most prominent band corresponded to the 
 
32
 
P-labeled
Cyclin B as shown. The preimmune antibody could immu-
noprecipitate none of these proteins (Fig. 7, lane 4). The
phosphorylation could not be observed in cell extracts pre-
pared from cells in S phase (data not shown). These results
strongly suggest that MPF phosphorylates Cdc20 and
Cdh1 during mitosis in vivo, while it cannot be completely
ruled out the possibility that another kinase coimmuno-
precipitated with anti–Cyclin B antibody phosphorylates
these proteins.
 
pCdc20 but Not pCdh1 Binds to APC during Mitosis
In Vivo
 
Next, we examined in vivo phosphorylation of Cdc20 and
Cdh1 during mitosis and the interaction of these phosphor-
ylated factors with APC in vivo. K562 cells were labeled
with [
 
32
 
P]orthophosphate during mitosis in vivo and the
APC was purified by immunoprecipitation with anti–
Cdc27 antibody. The 
 
32
 
P-labeled Cdc20 could be immuno-
precipitated with anti–Cdc20-specific antibody from this
purified APC (Fig. 8, lane 1) and from the total cell lysates
(Fig. 8, lane 2), indicating that Cdc20 can indeed be phos-
phorylated and binds to APC during mitosis in vivo. In
contrast, the 
 
32
 
P-labeled Cdh1 could not be immunopre-
cipitated with its specific antibody (Fig. 8, lane 3) from the
purified APC, whereas the 
 
32
 
P-labeled Cdh1 could be im-
munoprecipitated from the total cell lysates (Fig. 8, lane
4), demonstrating that Cdh1 can actually be phosphory-
lated but pCdh1 cannot interact with APC during mitosis
in vivo. These results perfectly agree with the findings
shown in the in vitro reconstituted system (Figs. 1–6).
 
Discussion
 
Taken together with the findings described above and
other observations recently reported, the scheme of regu-
lation of APC activity is depicted in Fig. 9. We showed in
this paper that phosphorylation of Cdc20 is required for
Cdc20-dependent APC activation at least in vitro (Fig. 2).
It has been reported that Cdc20 is expressed during G2
phase and mitosis (Fang et al., 1998a; Kramer et al., 1998)
and binds to APC (Figs. 6 A and 8) in early mitotic stages
Figure 5. pPlk synergistically acts on APC
activation with pCdc20 or Cdh1. (A) pPlk
synergistically acts on APC activation
with pCdc20. Purified APC was phosphor-
ylated by pPlk, and Cdc20 was phosphor-
ylated by MPF. The phosphorylated
(lanes 1–3 and 7–9) or untreated APC
(lanes 4–6) was incubated with GST-Cyclin
in the presence (lanes 4–9) or absence (lanes
1–3) of pCdc20 in the ubiquitination buffer
at 258C for 0, 10, and 30 min. Ubiquiti-
nated GST-Cyclin B was detected by im-
munoblotting with anti–Cyclin B1 anti-
body. (B) pPlk synergistically functions
with Cdh1 in APC activation. The same
experiments described in A were done us-
ing Cdh1 in place of pCdc20. 
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(Fang et al., 1998b). Whereas, Fang et al. (1998a) de-
scribed that the in vitro translated Cdc20, which might
be phosphorylated during preparation, activated APC in
vitro and that the phosphatase treatment of Cdc20 had no
effect on APC activity, it was recently demonstrated that
Cdc20 is clearly phosphorylated during mitosis in HeLa
cells (Kramer et al., 1998), and that Cdc20 is phosphory-
lated by MPF in 
 
Xenopus
 
 embryos (Lorca et al., 1998).
Actually, the possible Cdc2 phosphorylation site is con-
served in budding yeast Cdc20, fission yeast Slp1, and
mammalian Cdc20. Therefore, it is most likely that Cdc20
is indeed phosphorylated during mitosis in vivo. Taken to-
gether, we concluded that Cdc20 activates APC when it is
phosphorylated by MPF.
The activation of APC can be blocked by the binding of
Mad2 to pCdc20 (Fig. 2, A and B; He et al., 1997; Li et al.,
1997; Fang et al., 1998; Gorbsky et al., 1998; Hwang et al.,
1998; Kallio et al., 1998; Kim et al., 1998). Therefore, at
least two events may be required to activate APC at
metaphase–anaphase transition: release of Mad2 from
pCdc20 after spindle assembly checkpoint is released, and
phosphorylation of Cdc20 bound to APC by MPF or bind-
ing of pCdc20 to APC. Furthermore, we found that at least
in vitro APC activation can be suppressed by PKA (Figs. 4
and 6 A; Ishii et al., 1996), which phosphorylates two APC
subunits, APC1 and APC3 (Kotani et al., 1998). Thus, de-
phosphorylation of PKA phosphorylation sites on APC by
a specific phosphatase yet unidentified, which may be PP1
as previously suggested (Ishii et al., 1996), might also be
required for the onset of anaphase.
Mad2 cannot inhibit Cdh1-induced APC activation (Fig.
3 B), and pAPC can ubiquitinate Cyclin B even in the
presence of Mad2 (Fig. 5 A). Thus Mad2 inhibits APC
activation only through Cdc20. Further, the binding of
Cdc20 or pCdc20 to APC or pAPC was not affected by
Mad2 (Fig. 6 A), indicating that Mad2 inhibits the function
of pCdc20 but not the binding of pCdc20 to APC. Very re-
cently, it was reported that whereas Mad1, Mad2, Mad3/
Bub1, and Bub3 suppress Cdc20-dependent APC activa-
tion, Bub2 localized in the spindle pole body regulates
Cdh1-dependent APC activation (Alexandru et al., 1999;
Fesquet et al., 1999; Fraschini et al., 1999). Further de-
tailed functional analyses of the Mad family and Bub fam-
ily are required to clarify the molecular mechanisms of
spindle assembly checkpoint and of APC regulation.
Figure 6. Binding of Cdc20,
pCdc20, and Cdh1 to APC
and pAPC. (A) Purified APC
in S phase, which was pre-
pared by immunoprecipita-
tion with anti–Cdc27 anti-
body, was treated with pPlk
(lanes 7–12), or PKA (lanes
13–16), or without treatment
(lanes 1–6). Phosphorylated
or untreated APC was incu-
bated with T7-tagged human
Cdc20 (lanes 1, 3, 7, 9, and
13), pCdc20 (lanes 2, 4, 8, 10,
and 14), Cdh1 (lanes 5, 11,
and 15), or pCdh1 (lanes 6,
12, and 16), in the presence
(lanes 3, 4, 9, and 10) or ab-
sence of Mad2, washed well, and the proteins bound to APC were resolved by 7% SDS-PAGE. The bound proteins were detected by
immunoblotting with anti-T7 antibody. (B) The purified S phase APC was incubated with Cdc2-GST-Cyclin B and g-[32P]ATP in the
presence of Cdc20 (lanes 1 and 3) or Cdh1 (lane 2), and the 32P-labeled proteins were immunoprecipitated by anti–Cdc27 antibody (lanes
1 and 2) or by preimmune antibody (lane 3).
Figure 7. MPF phosphorylates Cdc20 and Cdh1 during mitosis in
vivo. The immunoprecipitates of anti–Cyclin B antibody from
mitotic K562 cell extracts were incubated with g-[32P]ATP,
washed with 1% SDS, diluted with the kinase buffer, and the la-
beled Cdc20 (lane 2) and Cdh1 (lane 3) were immunoprecipitated
with each specific antibody. Lane 1 shows the total 32P-labeled
proteins in the immunoprecipitates. Lane 4 shows the immuno-
precipitates with preimmune antibody. Right arrow indicates the
32P-labeled Cdc20 and Cdh1. Left arrow shows 32P-labeled Cyclin B. 
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It was clearly shown that pAPC can ubiquitinate Cyclin
B but not Cut2 in vitro, but it remains unclear whether
free pAPC actually exists during mitosis in vivo. It is most
likely that the majority of pAPC forms a complex with ei-
ther pCdc20 or Cdh1 that ubiquitinates Cyclin B in vivo.
Furthermore, phosphorylation of APC by pPlk may not be
essential for APC activation at the metaphase–anaphase
transition, but our results suggest that it is required for
complete Cyclin B ubiquitination in later stages of mitosis.
We showed here that pCdc20 and Cdh1, but neither
Cdc20 nor pCdh1 activates APC in vitro, and the following
switching mechanism from pCdc20 to Cdh1 could be spec-
ulated. When the cells enter anaphase after Cut2/Pds1 is
entirely degraded, the pAPC–pCdc20 complex steadily
ubiquitinates Cyclin B and, consequently, MPF activity
decreases by the end of mitosis. The pCdc20 can be de-
phosphorylated by a specific phosphatase and released
from pAPC or it may be degraded as previously suggested
(Fang et al., 1998a; Shirayama et al., 1998). When MPF ac-
tivity is high, Cdh1 is phosphorylated and remains inac-
tive, but when Cdc14 is activated, Cdh1 is dephosphory-
lated by Cdc14 as suggested (Visintin et al., 1998, 1999;
Shou et al., 1999) and binds to and activates APC. Conse-
quently, the pAPC–pCdc20 complex is replaced by the
pAPC–Cdh1 (or APC–Cdh1) complex in late mitosis. The
pAPC–Cdh1 or APC–Cdh1 complex further ubiquitinates
Cyclin B in late mitosis and G1 phase. Thus, the switch
mechanism from pCdc20 to Cdh1 may be dependent upon
the MPF activity during mitosis, and the MPF activity it-
self is controlled by the pCdc20- and Cdh1-dependent
APC activity.
Cdc20 has been reported to activate ubiquitination of
the factors regulating sister chromatid separation and
Cdh1 promotes ubiquitination of mitotic cyclins (Visintin
et al., 1997; Shirayama et al., 1998). However, it was re-
cently found that in 
 
Xenopus
 
 early embryos, Cdh1 is not
expressed (Lorca et al., 1998), which is consistent with the
observation that Cdh1 is not expressed before stage 13 in
 
Drosophila 
 
embryos (Sigrist and Lehner, 1997). It was also
described that Cdc20 regulates ubiquitination of both
Cut2/Pds1 and Cyclin B in the early embryonic cell cycle
(Lorca et al., 1998). Very recently, Clute and Pines (1999)
reported that ubiquitin-dependent proteolysis of Cyclin B
begins at metaphase–anaphase transition in HeLa cells,
which is consistent with the results obtained with clam em-
bryo (Hunt et al., 1992). These findings are consistent with
our observation that pCdc20 can activate ubiquitination
not only of Cut2/Pds1, but also of Cyclin B. Thus, pCdc20
alone may be enough for cells to go through mitosis with-
out Cdh1. However, in the somatic cell cycle, Cdh1 in ad-
dition to pCdc20, may be required for effective and com-
plete ubiquitination of Cyclin B in later stages of mitosis
and G1 phase.
We demonstrated in this paper that Cdh1 can be phos-
phorylated by MPF (Figs. 1 B and 7), and Cdh1 but not
pCdh1 binds to and activates APC only after dephosphor-
ylation (Figs. 3 B, 6, A and B, and 8). These in vitro results
Figure 8. Interaction of pCdc20 and Cdh1 with APC during mi-
tosis in vivo. K562 cells were labeled with 32P-orthophosphate
during mitosis, and the APC was purified by Resource Q chro-
matography and immunoprecipitation with anti–Cdc27 antibody.
The 32P-labeled Cdc20 was immunoprecipitated with anti–Cdc20
antibody from this purified APC (lane 1) and from the total cell
lysates (lane 2). The 32P-labeled Cdh1 was immunoprecipitated
with its specific antibody from the purified APC (lane 3) and
from the total cell lysates (lane 4). Arrows indicate pCdc20 and
pCdh1 phosphorylated in vivo.
Figure 9. Model of regulation of APC ac-
tivity.Kotani et al. Regulation of APC Activity 799
are consistent with in vivo data in budding yeast that the
dephosphorylated form of Cdh1/Hct1 activates APC (Za-
chariae et al., 1998b). It was recently described that Cdh1
is constantly expressed throughout the cell cycle (Fang et
al., 1998a; Kramer et al., 1998), binds to APC in late mito-
sis and G1 phase (Fang et al., 1998b), and is phosphory-
lated during mitosis in HeLa cells (Kramer et al., 1998). It
was also reported that Cdh1/Hct1 binding to APC is regu-
lated by cyclin-dependent kinases (Zachariae et al.,
1998b). Very recently, it was demonstrated that Cdc14 de-
phosphorylates Cdh1/Hct1 and inactivates APC (Visintin
et al., 1998). Further, it was found that the activation of
Cdc14 is regulated by Bub2/Byr4 and RENT complex (Al-
exandru et al., 1999; Shou et al., 1999; Visintin et al., 1999),
although it remains unresolved whether the regulation by
RENT complex works in the mammalian system. All these
results in vivo agree well with our results in vitro.
In our scheme, it is possible that Cdh1–APC complex
activity is maintained until late G1 phase, while it might be
diminished by the phosphorylation of Cdh1 with Cdk2,
Cdk4, or another unidentified specific kinase that is active
at G1/S transition (Amon et al., 1994). It has been re-
ported that the low level of Cyclin B is translated even in
G1 phase (Brandeis and Hunt, 1996). In the G1 phase,
APC–Cdh1 complex may, thus, effectively ubiquitinate
this newly translated Cyclin B to avoid activation of MPF.
The possible involvement of G1/S Cdks or other specific
kinases in Cdh1-dependent APC inactivation must be fur-
ther studied.
Patra and Dunphy (1998) recently reported that Cdc2-
Cyclin B phosphorylates APC3/Cdc27 and APC1/BIME of
Xenopus APC in the presence of the Xenopus Suc1/Cks1
protein, Xe-p9. We confirmed that in the presence of hu-
man Suc1/Cks1 (CksHs-1 or CksHs-2), MPF could phos-
phorylate APC1/Tsg24 and APC3/Cdc27 but not APC6/
Cdc16, whereas none of the APC core subunits could be
phosphorylated by MPF alone (Fig. 1 C). The MPF-acti-
vated Plk could phosphorylate APC1/Tsg24, APC3/Cdc27,
APC6/Cdc16, and one more additional unidentified pro-
tein as we previously showed (Kotani et al., 1998). It has
been reported that in Xenopus the phosphorylated APC
components during mitosis are at least APC1/Tsg24,
APC3/Cdc27, APC6/Cdc16, and APC8/Cdc23 (Peters et al.,
1996). Therefore, the kinase that phosphorylates Cdc23/
APC8 and may affect APC activity has not yet been iden-
tified. Furthermore, Patra and Dunphy (1998) have not
demonstrated that phosphorylation with Cdk1-Suc1/Cks1
actually activates ubiquitination of cyclin B. Very recently,
however, Shteinberg and Hershko (1999) demonstrated
that in early embryonic cell cycle Cdk1 activated Xenopus
APC in the presence of Suc1/Cks1. Further, Shteinberg
et al. (1999) described that phosphorylation of APC by
MPF is required for its stimulation by Cdc20. In contrast,
Kaiser et al. (1999) very recently reported that Cks1 nei-
ther bound to nor activated APC, but that it did regulate
proteasome activity in yeast. We also found that the APC
was not activated only by phosphorylation with MPF.
These data support the notion that MPF can phosphory-
late APC in the presence of Suc1/Cks1, but itself may not
be enough to completely activate APC, and that other ki-
nases like Plk and/or factors such as Cdc20 and Cdh1 are
required for full APC activation.
Our findings in vitro and in vivo are consistent with the
other in vivo observations (Fang et al., 1998a,b; Kramer
et al., 1998; Lorca et al., 1998), and strongly support the
notion that pCdc20 but not Cdc20 activates APC, and that
Cdh1 but not pCdh1 binds to and activates APC. There-
fore, phosphorylation and dephosphorylation of APC reg-
ulatory factors by MPF are critical for their binding to
APC and/or APC activation. The MPF activity itself is reg-
ulated by the pCdc20- and Cdh1-dependent APC activity,
and this feedback control precisely regulates APC activity.
Taken together, the APC activity is regulated by the phos-
phorylation and dephosphorylation of APC and of the
regulatory factors, Cdc20 and Cdh1, by MPF, Plk, PKA,
and PP1, as well as by the binding of positive and negative
regulatory factors, Cdc20, Cdh1, and Mad2, to APC.
These elaborate regulatory mechanisms might control the
precise progression of mitosis.
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